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ABSTRACT: Wereporta general strategy forcreating pro-
tein kinases in mammalian cells that are poised for very
rapid activation by light. By photoactivating a caged version
of MEK1, we demonstrate the speciﬁc, rapid, and receptor
independent activation of an artiﬁcial subnetworkwithinthe
Raf/MEK/ERK pathway. Time-lapsemicroscopy allowed us
to precisely characterize the kinetics of elementary steps in
the signaling cascade and provided insight into adaptive
feedback and rate-determining processes in the pathway.
S
ignal transduction pathways use cascades of protein and lipid
kinase mediated phosphorylation to elicit speciﬁc responses
to distinct extracellular stimuli. Kinase pathways are complex,
dynamic,multistepprocessesthatcross-talk,feed-backand-forward,
and contain elementary steps that may operate at very diﬀerent
rates. A complete, and ultimately quantitative, understanding of
kinase pathways will require: (1) an understanding of the net-
workconnectivityandregulationinspaceandtimeofeachkinase
and (2) a description of how the individual steps within a
pathway regulate the kinetics of signal transmission through
the pathway.
The utility of genetic or si-RNA-based approaches for under-
standing the architecture of kinase networks using constitutively
active,knocked-outorknock-downkinasesmaybecompromised
by the evolvability or adaptability of signaling networks in
responsetotheseslowlyeﬀectedperturbations.Inaddition,these
strategiesdonot,ingeneral,allowtheroleofkinasecatalysistobe
separated from other roles a kinase may play, for example, in
scaﬀolding signaling networks. These approaches also generally
fail to provide information about contributions of elementary
stepstothekineticsofsignaltransmission.Eﬀortstoreconstitute
kinasepathwaysinvitromaynotcapturethecomplexityofthein
vivosituationandmaybethwartedbythechallengeofexpressing
every signaling protein from the membrane to the nucleus.
Shokat and co-workers have addressed the creation of mutant
kinases that are selectively sensitized to inhibition by adenine
derivatives, allowing the creation of kinase alleles in which the
catalytic activity can be speciﬁcally inhibited within minutes by
the addition of a small molecule.
1 This approach has allowed
‘chemical-genetic’ inhibition of kinases, addressed many limita-
tions of classical genetics for loss of function studies, and
provided new insights into kinase network connectivity.
Strategies for the selective and rapid activation of the catalytic
activity of a single kinase in the cell would complement insights
gainedby classicalgeneticapproaches and chemical genetic inhi-
bition. In particular, rapid activation of a particular kinase might
allow ustoobservethekinetics ofstepswithinapathway thatare
unresolvedwithintheentirenetworkandprovideinsightintothe
temporal control of signal transmission in a pathway. Activatable
kinases might also provide tools to uncover the architecture of
pharmacologically important, time-dependent, adaptive control
processes,suchasfeedbackinhibition.Coleandco-workers have
demonstrated chemical rescue of an inactivating mutation in a
kinase,
2 Lawrence and co-workers demonstrated photochemical
destruction of an inhibitor leading to kinase activation,
3 and
Hahn and co-workers recently reported a promising strategy for
allosteric activation of chimeric kinases containing a rapamycin
binding domain.
4
We recently demonstrated that the photocaged lysine 1
(Figure 1) can be site-speciﬁcally incorporated into proteins in
Figure1. IsolatingasubnetworkinMAPkinasesignalingviagenetically
encoding a photocaged lysine in MEK1 active site. (a) Schematic of the
MAPkinasesignalingpathwayandthesynthetic,photoactivablesubnet-
work.(b)Caginganearuniversallyconservedlysine(K97)intheMEK1
active site inactivates the enzyme by sterically blocking ATP binding.
Decaging with light rapidly removes the caging group and activates the
kinase (ﬁgures created using Pymol and MEK1 structure PDB: 1S9J).
(c) Photocaged lysine 1.
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response to the amber codon in mammalian cells using the
PCKRS/tRNACUA pair.
5 This pair was synthetically evolved from
the pyrrolysyl-tRNA synthetase/tRNACUA pair that directs the
incorporation of pyrrolysine in certain methanogens. Here
we reporta new,potentiallygeneral, strategy forvery rapidlyand
selectivelyactivatingthecatalyticactivityofauser-deﬁnedkinase
within the cell using light, taking advantage of the PCKRS/
tRNACUA pair.
Our strategy for creating a kinase poised for photoactivation
involves: (1) replacing a near universally conserved lysine resi-
due, in the ATP binding pocket of the conserved catalytic domain,
that anchors and orientates ATP and is required for the phos-
phorylation activity of protein kinases,
6 with the photocaged
lysine1(Figure1) and(2)introducingactivatingmutations into
the kinase.
To begin to demonstrate the feasibility of this approach, we
created a photoactivatable version of the MAP kinase kinase
MEK1. MEK1iscentral to the Raf/MEK/ERK signaling pathway
(Figure1) andcontrolsdiverseresponses,includingcellprolifera-
tion, that are activated by growth factors or other extracellular
stimuli. Upon stimulation of the pathway, MEK1 is activated by
phosphorylationandphosphorylatesthedownstreamextracellular
signal-regulated protein kinases ERK1 and ERK2.
7 ERK1/2 are
phosphorylated on a threonine and a tyrosine, within a conserved
Thr-Glu-Tyr (TEY) motif.
8 To encode a caged version of MEK1
that would be fully active in resting conditions after light-induced
uncaging, we ﬁrst introduced an amber stop codon in place of the
codon for lysine 97 in the gene of A-MEK1-ΔN (a constitutively
active MEK1 mutant in which residues 30-49 are deleted;
9 A
denotes active), creating mek1-ΔN-97TAG.W h e nt r a n s i e n t l y
expressed with the PCKRS/tRNACUA pair in human embryonic
kidney (HEK)293ET cells grown in presence of 1 (2 mM),
mek1-ΔN-97TAG allows the expression of a full-length photo-
caged mutant C-MEK1-ΔN (C denotes that the catalytic residue
K97 is caged) [Figure S1, Supporting Information (SI)]. Im-
munoblotting showed that the expression level of C-MEK1-ΔN
was comparable with that obtained when tyrosine was incorpo-
rated instead of 1 in response to the amber codon using a human
tyrosine amber suppressor tRNA
Tyr
CUA and slightly lower than
that of the mutants A-MEK1-ΔN and D-MEK1-ΔN (inactive
MEK1 mutant with the inactivating mutation K97M; D denotes
dead) (Figure S1, SI).
To conﬁrm that the introduction of the photocaged lysine 1
prevents kinase activity, we coexpressed C-MEK1-ΔN with
ERK2 fused to an enhanced green ﬂuorescent protein (EGFP-
ERK2)inrestingHEK293ET cells.Immunoblottingrevealed no
phosphorylation of the TEY motif in both endogenous ERK1/2
and EGFP-ERK2 (Figures 2 and S2, SI), showing that the caged
lysine1blocksthecatalyticactivityofC-MEK1-ΔNaseﬃciently
as the K97 M mutation in D-MEK1-ΔN.
We next demonstrated that C-MEK1-ΔN could be activated
by light-induced uncaging. We illuminated cells expressing
C-MEK1-ΔN and EGFP-ERK2 for 1 min using a 365 nm light-
emitting diode (LED) lamp placed underneath the culture plate.
Phosphorylation of EGFP-ERK2 and endogenous ERK2 was
detectable by immunoblotting 1 min after illumination, with a
maximum phosphorylation after 10 min (Figure 2). Illumination
of cells coexpressing C-MEK1-ΔN and EGFP-ERK2 for increas-
ing times led to increased phosphorylation of EGFP-ERK2
(Figure S4, SI), demonstrating that it is possible to ﬁnely tune
the cellular concentration of active kinase by simply modulating
theilluminationtime.WhenC-MEK1-ΔNwasreplacedwiththe
inactive kinase D-MEK1-ΔN (Figure 2) or with no protein
(Figure S3, SI), there was no detectable phosphorylation of
EGFP-ERK2 upon illumination. These data demonstrate that
illumination alone is not suﬃcient to induce phosphorylation
of ERK.
To demonstrate that photoactivation of C-MEK1-ΔN led to
activation of ERK1/2, we probed the phosphorylation state of
two ERK1/2 downstream substrates: p90 ribosomal S6 kinase
p90RSK and the transcription factor Elk-1. Illumination of rest-
ing cells coexpressing C-MEK1-ΔN and EGFP-ERK2 led to an
increase of endogenous phosphorylated p90RSK and Elk-1,
which was not observed when D-MEK1-ΔN was used instead
of C-MEK1-ΔN or when the MEK1 inhibitor U0126 was added
(Figure S5, SI). These data demonstrate that photoactivation of
C-MEK1-ΔN allows the speciﬁc activation of a subnetwork of
the MAP kinase pathway in the cell, independent of extracellular
stimuli. In this subnetwork ERK1/2 is phosphorylated and
activated and then phosphorylates p90RSK and Elk-1.
We next investigated whether our ability to speciﬁcally and
rapidlyactivateasubnetworkofakinasepathwaymightenableus
to provide insights into signaling that are challenging to obtain
when the whole pathway is activated. Aside from its role as an
activator, MEK1 also acts as a cytoplasmic anchor protein for
ERK1/2.
10,11 Upon dual phosphorylation, ERK1/2 detaches
from MEK1 and its other cytoplasmic anchors and translocates
into the nucleus,
10,12 where itregulates geneexpression byphos-
phorylating transcription factors.
13 Nuclear ERK1/2 returns to
the cytoplasm upon deactivating dephosphorylation by nuclear
MAPK phosphatases (MKPs).
14,15
Stimulation of resting cells expressing wild-type MEK1 and
EGFP-ERK2 with epidermal growth factor (EGF, 100 ng/mL)
activates the entire MAP kinase pathway resulting in EGFP-
ERK2 translocation from the cytoplasm to the nucleus. Quanti-
ﬁcation of ﬂuorescence time-lapse microscopy images demon-
strates that the nuclear accumulation of EGFP-ERK2 exhibits
sigmoidalkinetics,withalagphaseof3minpriortorapidnuclear
accumulation of EGFP-ERK2 (Figure S6a,b, SI and movie 1).
The nuclear accumulation of EGFP-ERK2 peaks and then
dissipates to prestimulus levels, despite continued stimulation
(Figure S6a,b).
This type of desensitization to persistent stimuli is a well-
known eﬀect in cellular systems known as exact (or nearly
complete) adaptation
16 and is likely to involve negative feed-
back. However the balance between activation and desen-
sitization and the molecular targets of feedback are poorly
Figure 2. Speciﬁc phosphorylation of ERK2 upon photoactivation of
the caged MEK1. HEK293ET cells cotransfected with plasmids encod-
ing PCKRS, pyrrolysyl tRNACUA, EGFP-ERK2, and either A-MEK1-
ΔN-HA (A, lane 2), D-MEK1-ΔN-HA (D, lanes 3-6), or C-MEK1-
ΔN-HA (C, lanes 7-10) were grown in medium supplemented with 2
mMof1 and0.1%FBSfor24h.Cellsexpressing D-MEK1-ΔN-HAand
C-MEK1-ΔN-HA were illuminated with a 365 nm LED lamp for 60 s.
Cells were lysed 1, 10, and 60 min after illumination. Cell lysates were
resolved by SDS-PAGE, followed by immunoblotting (IB) with the
indicated antibodies.2126 dx.doi.org/10.1021/ja1109979 |J. Am. Chem. Soc. 2011, 133, 2124–2127
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understood. A very recent model for exact adaptation proposes
that it involves multiple ERK-dependent negative feedback steps,
including desensitization of upstream Ras-guanine nucleotide
exchange factor (GEF) recruitment by hyperphosphorylation of
Sos,desensitizationofupstreamRafisoformsthroughphosphor-
ylation,andtranscriptionalup-regulationofMAPKphosphatases
(MKPs) that dephosphorylate ERK (Figure S6c, SI).
17 Among
these, the desensitization of Raf, the kinase that directy
activates MEK1, is proposed to have the strongest eﬀect on
adaptation.
17
Inordertoobtainadditionalinsightsintotheelementarysteps
of this process, we characterized the dynamics of ERK2 nuclear
translocationusingaphotocagedMEK1poisedforphotoactivation.
FortheseexperimentswecreatedanewcagedMEK1(C-MEK1-
DD)byphotocagingtheconservedlysineK97ofA-MEK1-DD,a
constitutively active MEK1 in which Ser218 and Ser222, the
residues normally phosphorylated by Raf to activate MEK1, are
substitutedwithAspresiduestomimicthephosphorylatedstate
9
(see text S1 for detailed explanation of the requirement to create
a new caged MEK1 and Figure S7, SI for full characterization of
C-MEK1-DD).
First, we demonstrated that photoactivation of C-MEK1-DD
speciﬁcally induces ERK2 nuclear translocation through phospho-
rylation. Confocal ﬂuorescence imaging showed that C-MEK1-
DDretainsEGFP-ERK2inthecytoplasm,demonstratingthatits
anchoring function is maintained, while its catalytic activity is
eliminated (Figure S8a, SI). Upon illumination with a micro-
scope metal halide lamp equipped with a UV ﬁlter (2 s, 365 nm,
1 mW/cm
2), cells under resting conditions that show cytoplas-
micC-MEK1-DDandEGFP-ERK2,rapidlyaccumulatedEGFP-
ERK2 in the nucleus (Figure S8a,b, SI). A 4-fold increase in the
ratio of the nuclear to cytoplasmic EGFP ﬂuorescence F(n/c)
within10minfollowing illumination wasobserved(Figure S8b).
These experiments in combination with numerous additional
controls (see text S2 and Figure S8a,b) demonstrate that activa-
tion of ERK2 by MEK1-induced phosphorylation of the TEY
motifissuﬃcienttotriggerERK2nucleartranslocationinresting
cells.
Real-time measurements of EGFP-ERK2 nuclear transloca-
tion (Figure 3a,b and movie 3) show that the translocation
process in the subnetwork is initiated much faster after photo-
activation of C-MEK1-DD than for EGF-stimulated activation
of the whole pathway (t1/2 = 1.5 min vs 4.5 min, Figures 3b and
S9, SI). Moreover, in contrast to EGF stimulation, photoactiva-
tion of C-MEK1-DD allows the nuclear accumulation of EGFP-
ERK2tobesustainedforlongperiods(Figure3a,bandmovie3).
Thisdemonstrates that thepoolof photoactivated C-MEK1-DD
actsasastationarystimulusandthat,unlikethewholeEGFstim-
ulatedpathway,theactivityofthesubnetwork isnotsubjected to
exact adaptation. Since our light-sensitive subnetwork is insensi-
tive to upstream ERK-dependent negative feedback, because
C-MEK1-DD can only be activated by light and is not regulated
by Raf, this result is in accordance with a model in which ERK-
dependent Raf desensitization is a regulatory process more impor-
tant than the transcriptional up-regulation of MAPK phospha-
tases in ERK signaling adaption.
17
Our results also demonstrate that the activity of MAPK phos-
phatases is suﬃcient to counteract nuclear import of ERK1/2 by
promotingnucleardephosphorylationofERK1/2anditsexport,
14,15
leading to an apparent steady-state of nuclear ERK2. However
this process is not suﬃcient to produce an adaptive decrease in
ERK2 in the nucleus in these cells. To unveil the compensating
nuclear export of ERK2, we induced EGFP-ERK2 nuclear trans-
locationbyC-MEK1-DDphotoactivationandthenblockedMEK1-
induced ERK2 nuclear translocation by addition of the MEK1
inhibitor U0126. This caused a rapid loss of EGFP nuclear
ﬂuorescence (t1/2 < 3 min) (Figure 3d, Figure S10, SI, and
movie4),inaccordancewitharapiddephosphorylation-induced
nuclear export of the imported ERK2.
15
The curves for EGF stimulated translocation and photoacti-
vated translocationhave comparable slopes once translocation is
initiated (as judged by the slope when 50% of the net transloca-
tionhasoccurred),buttheinitiallagphaseintheEGFstimulated
experiment is much longer than in the photoactivated experi-
ment (compare Figures S6b, SI and 3b,e). These observations
suggest that steps upstream of MEK1 in the pathway function
introduceadelaypriortoactivatingthetranslocationprocessbut
do not signiﬁcantly aﬀect the translocation rate once transloca-
tionhasbegun.Therateoftranslocationistherefore setbetween
MEK1 and ERK2 in the pathway. This is consistent with the rate
of ERK2 phosphorylation being rate determining for nuclear
import.
Recent work has characterized the kinetics of nuclear accu-
mulationandphosphorylationofapreviouslyreportedERKmutant
(ERK1-Δ4) following EGF stimulation. Researchers have pro-
videdevidencethatthismutantaccumulatedinthenucleusmore
slowly than wild-type ERK and was phosphorylated more slowly
than wild-type ERK following EGF stimulation.
18 Consistent
Figure 3. EGFP-ERK2 nuclear translocation upon photoactivation of
the caged MEK1. (a) Representative EGFP-ERK2 subcellular ﬂuores-
cenceatdiﬀerenttimepointsafterphotoactivation(2s,365nm,1mW/
cm
2) of coexpressed C-MEK1-DD. Scale bars represent 5 μm (see
movie2).(b)NormalizedF(n/c)(ratioofnucleartocytoplasmicEGFP
ﬂuorescence intensities) as a function of time after photoactivation
(mean ( SD of 10 independent experiments). The gray line shows the
normalized F(n/c) observed when cells are stimulated with EGF (see
Figure S6 and movie 1, SI). (c) Scheme of the potential negative
feedback within the photoactivatable subnetwork. (d) U0126 (10 μM)
was added 8 min after photoactivation of C-MEK1-DD (black line),
control experiment without inhibitor addition is gray line (Figure S10
andmovie3,SI).(e)High-resolutionkineticsoftranslocationfollowing
C-MEK1-DD photoactivation (mean ( SD of 10 independent experi-
ments) isshown. Datawere ﬁtted withasigmoidal function (Figure S12
and movie 5, SI).2127 dx.doi.org/10.1021/ja1109979 |J. Am. Chem. Soc. 2011, 133, 2124–2127
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with these observations, we conﬁrmed that ERK2-Δ4w a s
phosphorylated more slowly and accumulated in the nucleus
more slowly than wild-type ERK following MEK1 photoactiva-
tion (see text S3, for detailed explanation, Figure S11, and
movie 4, SI). While these experiments demonstrate that phos-
phorylation of ERK2 can become rate determining when using a
mutant ERK2, this does not demonstrate conclusively that
MEK1-mediated ERK2 phosphorylation is rate-determining in
the native pathway with wild-type ERK2.
In vitro it is known that phosphorylation of ERK2 on each of
its phosphorylation sites by MEK1 is nonprocessive (distribu-
tive)
19 and that distributive phosphorylation of ERK1/2 leads to
ultrasensitive, switch-like, sigmoidal kinetics for formation of the
diphosphorylated form.
19,20 However in vivo, where scaﬀolds
and other proteins may organize and regulate kinases,
21 it is
unknown if sigmoidal kinetics for this elementary step are
conserved and whether these phosphorylations, or steps up-
stream of MEK, control ERK1/2 translocation.
18 We reasoned
thatifERK2phosphorylationbyMEK1isratedeterminingfor
nuclear import and the phosphorylation kinetics in vivo reﬂect
those seen in vitro, then we should observe sigmoidal kinetics
of ERK2 nuclear import following MEK1 photoactivation.
Indeed the high temporal resolution of our method allowed
us to directly observe sigmoidal kinetics for ERK2 import
uponphotoactivationofC-MEK1-DD(Figures3eandS12and
movie 5, SI), consistent with the suggestion that ERK2 import
rate is, at least in part, determined by distributive dual
phosphorylation.
Inconclusion,wehavedemonstrateda—potentiallygeneral—
strategy for creating kinases that can be activated in living
mammalian cells by a rapid light pulse. This approach allows
the design of subnetworks controlled solely by light, which
enables the study of the kinetics of single steps in signaling
cascades and the dissection of temporal regulation. Due to the
substantialconservation ofthetargetedlysineresidue(presentin
95% of human protein kinases),
6 the light-activation method
reported here should be generally and readily applicable to
creating photoactivated versions of other protein kinases. More-
over, by applying the lysine photocaging to each kinase in a
pathway, further precise quantitative insights into the kinetics of
kinase networks, and the substrates of individual kinases will be
possible. Such quantitative insights in speciﬁcally and rapidly
activatedsingle-cellsubnetworkswillhelptorapidlyconstrainthe
experimental parameters in quantitative models of signal trans-
duction and may ultimately inform pharmacological strat-
egies.
22
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